Correction to: The Turkish Clinical Microbiology and Infectious Diseases Society (KLİMİK) Evidence-Based Guideline for the Diagnosis and Treatment of Brucellosis, 2023

Klimik Dergisi/Klimik Journal 2026 Open access

Read full text
Authors: Serap Şimşek Yavuz, Selçuk Özger, Aysun Benli, Can Ateş, Mehtap Aydın, Gökhan Aygün, Alpay Azap, Özlem Kurt Azap, Seniha Basaran, Neşe Demirtürk, Önder Ergönül, Aysel Kocagül-Çelikbaş
+5 more Ferit Kuşçu, Elif Mukime Sarıcaoğlu, Selda Sayın-Kutlu, Nesrin Türker, Emine Türkoğlu-Yılmaz
DOI: 10.36519/kd.2026.5533
Cited by: 1

Abstract

CORRECTION NOTE Two corrections have been made to the original version of this article, published on February 2, 2023: In Table 3, the information ‘DOX tablet 200 mg/day, single dose, oral +’ under the headings 1)Infective Endocarditis associated with Brucella spp. and 2) Neurobrucellosis has been corrected to: ‘DOX tablet 200 mg/day, 2 doses, oral +’. Corrected article: https://doi.org/10.36519/kd.2023.4576

Fields of Study & Subjects

Brucella: diagnosis epidemiology treatment Burkholderia infections and melioidosis Leptospirosis research and findings

Publication details

Journal / source
Klimik Dergisi/Klimik Journal
Publisher
Doc Design and Informatics Co. Ltd.
Publication date
14 February 2026